Home/Filings/4/0000914190-21-000344
4//SEC Filing

Lobo Wesley S. 4

Accession 0000914190-21-000344

CIK 0001196298other

Filed

Sep 2, 8:00 PM ET

Accepted

Sep 3, 4:29 PM ET

Size

7.5 KB

Accession

0000914190-21-000344

Insider Transaction Report

Form 4
Period: 2021-09-01
Lobo Wesley S.
Chief Marketing Officer
Transactions
  • Award

    Stock Option (right to buy)

    2021-09-01+57,36857,368 total
    Exercise: $8.47Exp: 2031-09-01Common Stock (57,368 underlying)
Holdings
  • Stock Optoin (right to buy)

    Exercise: $8.66Exp: 2031-02-16Common Stock (114,178 underlying)
    114,178
  • Common Stock

    41,557
Footnotes (3)
  • [F1]Includes (i) 20,557 shares of restricted stock for which the risk of forfeiture will lapse on 2/16/22; and (ii) 20,000 shares of restricted stock for which the risk of forfeiture will lapse as to 5,000 shares on each of 2/16/22, 2/16/23, 2/16/24 and 2/16/25.
  • [F2]Options to purchase 28,545 shares vest on 2/16/22 and options to purchase 85,633 shares vest quarterly in 12 equal amounts commencing on 5/16/22.
  • [F3]Options to purchase 14,342 shares vest on 9/1/22 and options to purchase 43,026 shares vest quarterly in 12 equal amounts commencing on 12/1/22.

Issuer

NEPHROS INC

CIK 0001196298

Entity typeother

Related Parties

1
  • filerCIK 0001841597

Filing Metadata

Form type
4
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 4:29 PM ET
Size
7.5 KB